Listed

Repligen Corp

RGENNasdaqCIK 730272HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$204.1m, Q2 FY2026
Operating income$14.0m, Q2 FY2026
Net income$5.0m, Q2 FY2026
Repligen Corp, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m141Revenue, Q3 FY2023, three months to 2023-09-30$141.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure167Revenue, Q4 FY2023, three months to 2023-12-31$166.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure153Revenue, Q1 FY2024, three months to 2024-03-31$153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure159Revenue, Q2 FY2024, three months to 2024-06-30$158.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure155Revenue, Q3 FY2024, three months to 2024-09-30$154.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure168Revenue, Q4 FY2024, three months to 2024-12-31$167.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure169Revenue, Q1 FY2025, three months to 2025-03-31$169.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure182Revenue, Q2 FY2025, three months to 2025-06-30$182.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure189Revenue, Q3 FY2025, three months to 2025-09-30$188.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure198Revenue, Q4 FY2025, three months to 2025-12-31$197.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure194Revenue, Q1 FY2026, three months to 2026-03-31$194.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure204Revenue, Q2 FY2026, three months to 2026-06-30$204.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Cost of revenue$m105Cost of revenue, Q3 FY2023, three months to 2023-09-30$104.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure88.1Cost of revenue, Q4 FY2023, three months to 2023-12-31$88.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure76.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$76.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure77.3Cost of revenue, Q2 FY2024, three months to 2024-06-30$77.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure77.4Cost of revenue, Q3 FY2024, three months to 2024-09-30$77.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure129Cost of revenue, Q4 FY2024, three months to 2024-12-31$128.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure77.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$77.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure89.4Cost of revenue, Q2 FY2025, three months to 2025-06-30$89.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure88.3Cost of revenue, Q3 FY2025, three months to 2025-09-30$88.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure94.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$94.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure86.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$86.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure94.1Cost of revenue, Q2 FY2026, three months to 2026-06-30$94.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m10.6Research and development, Q3 FY2023, three months to 2023-09-30$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure10.3Research and development, Q4 FY2023, three months to 2023-12-31$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure11.2Research and development, Q1 FY2024, three months to 2024-03-31$11.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure10.6Research and development, Q2 FY2024, three months to 2024-06-30$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure9.7Research and development, Q3 FY2024, three months to 2024-09-30$9.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure11.7Research and development, Q4 FY2024, three months to 2024-12-31$11.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure12.1Research and development, Q1 FY2025, three months to 2025-03-31$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure14.0Research and development, Q2 FY2025, three months to 2025-06-30$14.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure14.2Research and development, Q3 FY2025, three months to 2025-09-30$14.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure13.1Research and development, Q4 FY2025, three months to 2025-12-31$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure14.5Research and development, Q1 FY2026, three months to 2026-03-31$14.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure14.4Research and development, Q2 FY2026, three months to 2026-06-30$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Selling, general and administrative$m55.6Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$55.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure57.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$57.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure61.8Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$61.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure65.5Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$65.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure75.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$75.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure60.5Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$60.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure70.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$70.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure70.9Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$70.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure73.7Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$73.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure74.4Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$74.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure76.5Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$76.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure76.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$76.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Operating income$m4.7Operating income, Q3 FY2023, three months to 2023-09-30$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure9.9Operating income, Q4 FY2023, three months to 2023-12-31$9.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure3.8Operating income, Q1 FY2024, three months to 2024-03-31$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure5.5Operating income, Q2 FY2024, three months to 2024-06-30$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure(7.8)Operating income, Q3 FY2024, three months to 2024-09-30−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure(36.5)Operating income, Q4 FY2024, three months to 2024-12-31−$36.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure6.6Operating income, Q1 FY2025, three months to 2025-03-31$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure13.9Operating income, Q2 FY2025, three months to 2025-06-30$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure16.8Operating income, Q3 FY2025, three months to 2025-09-30$16.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure17.9Operating income, Q4 FY2025, three months to 2025-12-31$17.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure15.9Operating income, Q1 FY2026, three months to 2026-03-31$15.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure14.0Operating income, Q2 FY2026, three months to 2026-06-30$14.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Interest expense$m0.3Interest expense, Q3 FY2023, three months to 2023-09-30$269.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-10-31, accession 0000950170-23-056871.Report this figure1.1Interest expense, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-22, accession 0000950170-24-018809. Derived: 12-month figure less the 9-month figure.Report this figure4.9Interest expense, Q1 FY2024, three months to 2024-03-31$4.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-01, accession 0000950170-24-051310.Report this figure5.0Interest expense, Q2 FY2024, three months to 2024-06-30$5.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-07-30, accession 0000950170-24-087981.Report this figure5.1Interest expense, Q3 FY2024, three months to 2024-09-30$5.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure5.5Interest expense, Q4 FY2024, three months to 2024-12-31$5.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure5.3Interest expense, Q1 FY2025, three months to 2025-03-31$5.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure5.4Interest expense, Q2 FY2025, three months to 2025-06-30$5.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure5.4Interest expense, Q3 FY2025, three months to 2025-09-30$5.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure5.5Interest expense, Q4 FY2025, three months to 2025-12-31$5.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure5.6Interest expense, Q1 FY2026, three months to 2026-03-31$5.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure5.7Interest expense, Q2 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Income tax$m(5.5)Income tax, Q3 FY2023, three months to 2023-09-30−$5.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure18.3Income tax, Q4 FY2023, three months to 2023-12-31$18.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure0.4Income tax, Q1 FY2024, three months to 2024-03-31$399.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure3.3Income tax, Q2 FY2024, three months to 2024-06-30$3.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure(0.5)Income tax, Q3 FY2024, three months to 2024-09-30−$495.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure(4.7)Income tax, Q4 FY2024, three months to 2024-12-31−$4.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure2.1Income tax, Q1 FY2025, three months to 2025-03-31$2.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure3.3Income tax, Q2 FY2025, three months to 2025-06-30$3.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure2.2Income tax, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure5.8Income tax, Q4 FY2025, three months to 2025-12-31$5.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure(6.6)Income tax, Q1 FY2026, three months to 2026-03-31−$6.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure9.1Income tax, Q2 FY2026, three months to 2026-06-30$9.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Net income$m16.9Net income, Q3 FY2023, three months to 2023-09-30$16.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure(16.5)Net income, Q4 FY2023, three months to 2023-12-31−$16.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure3.3Net income, Q1 FY2024, three months to 2024-03-31$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure5.7Net income, Q2 FY2024, three months to 2024-06-30$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure(0.7)Net income, Q3 FY2024, three months to 2024-09-30−$654.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure(33.9)Net income, Q4 FY2024, three months to 2024-12-31−$33.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure5.8Net income, Q1 FY2025, three months to 2025-03-31$5.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure14.9Net income, Q2 FY2025, three months to 2025-06-30$14.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure14.9Net income, Q3 FY2025, three months to 2025-09-30$14.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure13.3Net income, Q4 FY2025, three months to 2025-12-31$13.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure8.3Net income, Q1 FY2026, three months to 2026-03-31$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure5.0Net income, Q2 FY2026, three months to 2026-06-30$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Diluted EPS$ per share0.30Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figurenot reported0.06Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure0.10Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure(0.01)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figurenot reported0.10Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure0.26Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure0.26Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figurenot reported0.15Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure0.09Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Basic EPS$ per share0.30Basic EPS, Q3 FY2023, three months to 2023-09-30$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figurenot reported0.06Basic EPS, Q1 FY2024, three months to 2024-03-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure0.10Basic EPS, Q2 FY2024, three months to 2024-06-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure(0.01)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figurenot reported0.10Basic EPS, Q1 FY2025, three months to 2025-03-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure0.26Basic EPS, Q2 FY2025, three months to 2025-06-30$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure0.27Basic EPS, Q3 FY2025, three months to 2025-09-30$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figurenot reported0.15Basic EPS, Q1 FY2026, three months to 2026-03-31$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure0.09Basic EPS, Q2 FY2026, three months to 2026-06-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure

Balance sheet

Cash and equivalents$606.8m, Q2 FY2026
Long-term debt$551.0m, Q2 FY2026
Shareholders' equity$2.11bn, Q2 FY2026
Repligen Corp, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m631Cash and equivalents, Q3 FY2023, at 2023-09-30$630.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2024-11-18, accession 0000950170-24-127841.Report this figure751Cash and equivalents, FY2023, at 2023-12-31$751.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-14, accession 0000950170-25-038999.Report this figure781Cash and equivalents, Q1 FY2024, at 2024-03-31$780.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2024-11-18, accession 0000950170-24-127844.Report this figure809Cash and equivalents, Q2 FY2024, at 2024-06-30$809.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2024-11-18, accession 0000950170-24-127845.Report this figure784Cash and equivalents, Q3 FY2024, at 2024-09-30$784.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure757Cash and equivalents, FY2024, at 2024-12-31$757.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-076528.Report this figure697Cash and equivalents, Q1 FY2025, at 2025-03-31$697.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure709Cash and equivalents, Q2 FY2025, at 2025-06-30$708.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure749Cash and equivalents, Q3 FY2025, at 2025-09-30$748.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure566Cash and equivalents, FY2025, at 2025-12-31$566.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure583Cash and equivalents, Q1 FY2026, at 2026-03-31$582.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure607Cash and equivalents, Q2 FY2026, at 2026-06-30$606.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Current assets$m980Current assets, Q3 FY2023, at 2023-09-30$980.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2024-11-18, accession 0000950170-24-127841.Report this figure1,111Current assets, FY2023, at 2023-12-31$1.11bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-14, accession 0000950170-25-038999.Report this figure1,131Current assets, Q1 FY2024, at 2024-03-31$1.13bn. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2024-11-18, accession 0000950170-24-127844.Report this figure1,157Current assets, Q2 FY2024, at 2024-06-30$1.16bn. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2024-11-18, accession 0000950170-24-127845.Report this figure1,132Current assets, Q3 FY2024, at 2024-09-30$1.13bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure1,066Current assets, FY2024, at 2024-12-31$1.07bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076528.Report this figure1,032Current assets, Q1 FY2025, at 2025-03-31$1.03bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure1,057Current assets, Q2 FY2025, at 2025-06-30$1.06bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure1,096Current assets, Q3 FY2025, at 2025-09-30$1.10bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure1,137Current assets, FY2025, at 2025-12-31$1.14bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure1,161Current assets, Q1 FY2026, at 2026-03-31$1.16bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure1,201Current assets, Q2 FY2026, at 2026-06-30$1.20bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Total assets$m2,523Total assets, Q3 FY2023, at 2023-09-30$2.52bn. XBRL concept us-gaap:Assets. 10-Q/A filed 2024-11-18, accession 0000950170-24-127841.Report this figure2,831Total assets, FY2023, at 2023-12-31$2.83bn. XBRL concept us-gaap:Assets. 10-K filed 2025-03-14, accession 0000950170-25-038999.Report this figure2,854Total assets, Q1 FY2024, at 2024-03-31$2.85bn. XBRL concept us-gaap:Assets. 10-Q/A filed 2024-11-18, accession 0000950170-24-127844.Report this figure2,866Total assets, Q2 FY2024, at 2024-06-30$2.87bn. XBRL concept us-gaap:Assets. 10-Q/A filed 2024-11-18, accession 0000950170-24-127845.Report this figure2,831Total assets, Q3 FY2024, at 2024-09-30$2.83bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure2,830Total assets, FY2024, at 2024-12-31$2.83bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-076528.Report this figure2,852Total assets, Q1 FY2025, at 2025-03-31$2.85bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure2,902Total assets, Q2 FY2025, at 2025-06-30$2.90bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure2,924Total assets, Q3 FY2025, at 2025-09-30$2.92bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure2,950Total assets, FY2025, at 2025-12-31$2.95bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure2,931Total assets, Q1 FY2026, at 2026-03-31$2.93bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure2,950Total assets, Q2 FY2026, at 2026-06-30$2.95bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Current liabilities$m379Current liabilities, Q3 FY2023, at 2023-09-30$378.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2024-11-18, accession 0000950170-24-127841.Report this figure165Current liabilities, FY2023, at 2023-12-31$164.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-14, accession 0000950170-25-038999.Report this figure182Current liabilities, Q1 FY2024, at 2024-03-31$181.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2024-11-18, accession 0000950170-24-127844.Report this figure175Current liabilities, Q2 FY2024, at 2024-06-30$174.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2024-11-18, accession 0000950170-24-127845.Report this figure108Current liabilities, Q3 FY2024, at 2024-09-30$108.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure127Current liabilities, FY2024, at 2024-12-31$126.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076528.Report this figure152Current liabilities, Q1 FY2025, at 2025-03-31$152.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure123Current liabilities, Q2 FY2025, at 2025-06-30$123.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure131Current liabilities, Q3 FY2025, at 2025-09-30$131.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure136Current liabilities, FY2025, at 2025-12-31$135.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure126Current liabilities, Q1 FY2026, at 2026-03-31$126.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure133Current liabilities, Q2 FY2026, at 2026-06-30$132.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Total liabilities$m549Total liabilities, Q3 FY2023, at 2023-09-30$549.0m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2024-11-18, accession 0000950170-24-127841.Report this figure866Total liabilities, FY2023, at 2023-12-31$866.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-14, accession 0000950170-25-038999.Report this figure888Total liabilities, Q1 FY2024, at 2024-03-31$888.1m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2024-11-18, accession 0000950170-24-127844.Report this figure882Total liabilities, Q2 FY2024, at 2024-06-30$881.6m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2024-11-18, accession 0000950170-24-127845.Report this figure814Total liabilities, Q3 FY2024, at 2024-09-30$814.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure857Total liabilities, FY2024, at 2024-12-31$856.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-076528.Report this figure867Total liabilities, Q1 FY2025, at 2025-03-31$866.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure840Total liabilities, Q2 FY2025, at 2025-06-30$839.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure841Total liabilities, Q3 FY2025, at 2025-09-30$840.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure844Total liabilities, FY2025, at 2025-12-31$843.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure825Total liabilities, Q1 FY2026, at 2026-03-31$825.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure838Total liabilities, Q2 FY2026, at 2026-06-30$838.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported526Long-term debt, FY2024, at 2024-12-31$525.6m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-26, accession 0001193125-26-076528.Report this figurenot reportednot reported538Long-term debt, Q3 FY2025, at 2025-09-30$537.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure542Long-term debt, FY2025, at 2025-12-31$542.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure547Long-term debt, Q1 FY2026, at 2026-03-31$546.6m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure551Long-term debt, Q2 FY2026, at 2026-06-30$551.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure
Shareholders' equity$m1,974Shareholders' equity, Q3 FY2023, at 2023-09-30$1.97bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure1,965Shareholders' equity, FY2023, at 2023-12-31$1.96bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-076528.Report this figure1,966Shareholders' equity, Q1 FY2024, at 2024-03-31$1.97bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure1,984Shareholders' equity, Q2 FY2024, at 2024-06-30$1.98bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure2,017Shareholders' equity, Q3 FY2024, at 2024-09-30$2.02bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure1,973Shareholders' equity, FY2024, at 2024-12-31$1.97bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure1,985Shareholders' equity, Q1 FY2025, at 2025-03-31$1.99bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure2,062Shareholders' equity, Q2 FY2025, at 2025-06-30$2.06bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure2,083Shareholders' equity, Q3 FY2025, at 2025-09-30$2.08bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure2,106Shareholders' equity, FY2025, at 2025-12-31$2.11bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure2,105Shareholders' equity, Q1 FY2026, at 2026-03-31$2.11bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure2,112Shareholders' equity, Q2 FY2026, at 2026-06-30$2.11bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure

Cash flow

Operating cash flow$32.8m, Q2 FY2026
Capital expenditure$5.3m, Q2 FY2026
Repligen Corp, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m39.2Operating cash flow, Q3 FY2023, three months to 2023-09-30$39.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-18, accession 0000950170-24-127846. Derived: 9-month figure less the 6-month figure.Report this figure29.1Operating cash flow, Q4 FY2023, three months to 2023-12-31$29.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure44.7Operating cash flow, Q1 FY2024, three months to 2024-03-31$44.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure42.2Operating cash flow, Q2 FY2024, three months to 2024-06-30$42.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105166. Derived: 6-month figure less the 3-month figure.Report this figure49.3Operating cash flow, Q3 FY2024, three months to 2024-09-30$49.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264666. Derived: 9-month figure less the 6-month figure.Report this figure39.2Operating cash flow, Q4 FY2024, three months to 2024-12-31$39.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure15.0Operating cash flow, Q1 FY2025, three months to 2025-03-31$15.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure28.6Operating cash flow, Q2 FY2025, three months to 2025-06-30$28.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001193125-26-323773. Derived: 6-month figure less the 3-month figure.Report this figure48.1Operating cash flow, Q3 FY2025, three months to 2025-09-30$48.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264666. Derived: 9-month figure less the 6-month figure.Report this figure25.7Operating cash flow, Q4 FY2025, three months to 2025-12-31$25.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure28.3Operating cash flow, Q1 FY2026, three months to 2026-03-31$28.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure32.8Operating cash flow, Q2 FY2026, three months to 2026-06-30$32.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001193125-26-323773. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m8.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$8.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-18, accession 0000950170-24-127846. Derived: 9-month figure less the 6-month figure.Report this figure11.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$11.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure8.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$8.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure4.8Capital expenditure, Q2 FY2024, three months to 2024-06-30$4.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105166. Derived: 6-month figure less the 3-month figure.Report this figure7.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$7.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264666. Derived: 9-month figure less the 6-month figure.Report this figure5.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$5.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure3.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure7.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$7.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001193125-26-323773. Derived: 6-month figure less the 3-month figure.Report this figure4.7Capital expenditure, Q3 FY2025, three months to 2025-09-30$4.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264666. Derived: 9-month figure less the 6-month figure.Report this figure8.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$8.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076528. Derived: 12-month figure less the 9-month figure.Report this figure4.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$4.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure5.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$5.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001193125-26-323773. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)56.64m, Q2 FY2026
Repligen Corp, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3057,304 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2024-11-18, accession 0000950170-24-127841.Report this figure0.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3157,049 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2024-11-18, accession 0000950170-24-127844.Report this figure0.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3056,858 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2024-11-18, accession 0000950170-24-127845.Report this figure0.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3056,940 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-18, accession 0000950170-24-127846.Report this figure0.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3156,531 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-29, accession 0000950170-25-060156.Report this figure0.1Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3056,434 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105166.Report this figure0.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3056,012 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure56.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3156,558,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure56.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3056,510,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure0.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3056,532 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264666.Report this figure56.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3156,666,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-208954.Report this figure56.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3056,638,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure

Shares outstanding: 56.44mShares outstanding, period not labelled, at 2026-07-2456,435,621 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-29, accession 0001193125-26-323773.Report this figure at Jul 24, 2026, from the cover of the 10-Q filed Jul 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. Listed shows no prices and gives no investment advice.